Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-225895
Filing Date
2012-05-10
Accepted
2012-05-10 17:11:01
Documents
12
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d338151d10q.htm 10-Q 432934
2 MANUFACTURING AND SUPPLY AGREEMENT d338151dex101.htm EX-10.1 276984
3 MANUFACTURING AND SUPPLY AGREEMENT d338151dex103.htm EX-10.3 91464
4 RULE 13A-14(A)/15D-14(A) CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER d338151dex311.htm EX-31.1 9201
5 RULE 13A-14(A)/15D-14(A) CERTIFICATIONS OF CHIEF FINANCIAL OFFICER d338151dex312.htm EX-31.2 9174
6 18 U.S.C. SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d338151dex321.htm EX-32.1 3632
7 18 U.S.C. SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER d338151dex322.htm EX-32.2 3611
  Complete submission text file 0001193125-12-225895.txt   1595898

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cort-20120331.xml EX-101.INS 76521
9 XBRL TAXONOMY EXTENSION SCHEMA cort-20120331.xsd EX-101.SCH 8651
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cort-20120331_cal.xml EX-101.CAL 25963
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20120331_lab.xml EX-101.LAB 86571
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20120331_pre.xml EX-101.PRE 51008
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 12831248
SIC: 2834 Pharmaceutical Preparations